These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. Johnson MD; Campbell LK; Campbell RK Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925 [TBL] [Abstract][Full Text] [Related]
10. Treatment of diabetes in patients with severe obesity. Scheen AJ Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290 [TBL] [Abstract][Full Text] [Related]
11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Kobayashi K; Amemiya S; Higashida K; Ishihara T; Sawanobori E; Kobayashi K; Mochizuki M; Kikuchi N; Tokuyama K; Nakazawa S Metabolism; 2000 Feb; 49(2):186-91. PubMed ID: 10690942 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance syndrome: options for treatment. Granberry MC; Fonseca VA South Med J; 1999 Jan; 92(1):2-15. PubMed ID: 9932820 [TBL] [Abstract][Full Text] [Related]
14. The role of troglitazone in treating the insulin resistance syndrome. Granberry MC; Schneider EF; Fonseca VA Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of diabetes and obesity in the United States. Muhammad S Compend Contin Educ Dent; 2004 Mar; 25(3):195-8, 200, 202; quiz 204. PubMed ID: 15641325 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes. Ortiz-Flores AE; Luque-RamÃrez M; Escobar-Morreale HF Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728 [TBL] [Abstract][Full Text] [Related]
17. Effects of troglitazone on insulin sensitivity. Henry RR Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499 [TBL] [Abstract][Full Text] [Related]
18. Current management strategies for coexisting diabetes mellitus and obesity. Scheen AJ Drugs; 2003; 63(12):1165-84. PubMed ID: 12790691 [TBL] [Abstract][Full Text] [Related]
19. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Legro RS; Castracane VD; Kauffman RP Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302 [TBL] [Abstract][Full Text] [Related]